BUDESONIDE ZENTIVA 0.5 mg/2 ml, suspension for inhalation by nebulizer in a single-dose container 20 single-dose containers of 2 ml
Active ingredients: Budesonide
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for inhalation by nebulizer20 single-dose containers of 2 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BUDESONIDE ZENTIVA 0,5 mg/2 ml, suspension pour inhalation par nébuliseur en récipient unidose
- Pharmaceutical form
- suspension pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 20 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 2 ml en sachets polytéréphtalate (PET) aluminium polyéthylène de (4x5)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Mar 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60512521CIP73020232CIP133400930202326Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUDÉSONIDEsuspension | 0,5 mg · un récipient unidose de 2 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.